Based on SAVA Yahoo Finance historical volatility measures, the stock’s implied volatility is nearing 75%, reflecting heightened option premiums. Traders are pricing in big moves, aligning with biotech’s reputation for sudden swings. On the other side, the drawbacks of small cap investing relate to the broader economy and the nature of the stocks and the firms themselves. Since small cap stocks have lower prices, their shares are more open to manipulation and pump and dump scams designed to lure unsuspecting investors to buy the shares. Additionally, small caps typically do not perform well in a slow economy as their more modest balance sheets provide them with inadequate buffers against prolonged periods of revenue drops and economic slowdowns. Such statements are based on our current expectations and projections about future events. Such statements speak only as of the date of this news release and are subject to a number of risks, uncertainties and assumptions, including, but not limited to, those risks relating to the ability to advance preclinical studies related to TSC-related epilepsy, and other potential indications, the ability to successfully carry out the Company’s obligations under the Yale License Agreement, the ability to efficiently discontinue the Company’s Alzheimer’s disease development program, and other risks inherent in drug discovery and development or specific to Cassava Sciences, Inc., as described in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, and future reports to be filed with the SEC. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from expectations in any forward-looking statement. In light of these risks, uncertainties and assumptions, the forward-looking statements and events discussed in this news release are inherently uncertain and may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, we disclaim any intention or responsibility for updating or revising any forward-looking statements. For further information regarding these and other risks related to our business, investors should consult our filings with the SEC, which are available on the SEC's website at www.sec.gov . Trend patterns on SAVA Yahoo Finance demonstrate a consolidation range between $21 and $
